Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications